VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 333 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2016. The put-call ratio across all filers is 1.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $385,000 | -69.2% | 15,700 | +27.6% | 0.03% | -69.8% |
| Q4 2015 | $1,250,000 | -43.0% | 12,300 | 0.0% | 0.09% | -43.0% |
| Q3 2015 | $2,194,000 | -19.7% | 12,300 | 0.0% | 0.15% | -11.7% |
| Q2 2015 | $2,732,000 | +11.8% | 12,300 | 0.0% | 0.17% | +19.6% |
| Q1 2015 | $2,443,000 | +38.8% | 12,300 | 0.0% | 0.14% | +36.2% |
| Q4 2014 | $1,760,000 | +9.0% | 12,300 | 0.0% | 0.10% | +11.7% |
| Q3 2014 | $1,614,000 | +4.1% | 12,300 | 0.0% | 0.09% | -3.1% |
| Q2 2014 | $1,551,000 | -36.5% | 12,300 | -40.9% | 0.10% | -45.2% |
| Q4 2013 | $2,442,000 | – | 20,800 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |